Pantheon Vision, a Baltimore, Maryland-based ophthalmic medical device company, raised $2.5M in seed funding.
The round was led by KeraLink International.
The company intends to use the funds to develop bioengineered corneal implants to reduce reliance on donated corneal tissue – often unavailable in LMICs.
Led by John Sheets, Ph.D, Pantheon Vision is an early-stage ophthalmic medical device company committed to developing advanced bioengineered solutions to treat corneal blindness and restore vision for people worldwide.
Dr. Sheets has led companies including Hoya and Elisar, and R&D organizations at Alcon, Bausch & Lomb, and Johnson & Johnson. He also served the Food and Drug Administration heading its Office of Device Evaluation.
FinSMEs
14/11/2023